Skip to main content

Echocardiographic Features of Constrictive Cardiomyopathy or Pericarditis

 

Watch the above case to get an idea.

Echocardiographic Features of Constrictive Cardiomyopathy


Constrictive cardiomyopathy (CCM) is a rare but clinically significant condition characterized by impaired diastolic filling due to the rigid or fibrotic nature of the myocardium. Echocardiography plays a crucial role in the diagnosis and management of CCM, offering insights into the structural and functional abnormalities of the heart.

1. Septal Bounce: One of the hallmark echocardiographic findings in CCM is the presence of septal bounce. This refers to paradoxical motion of the interventricular septum, where it moves towards the left ventricle during early diastole and then recoils back towards the right ventricle during late diastole. This motion is indicative of the restrictive physiology seen in CCM.

2. Diastolic Dysfunction: Echocardiography reveals impaired diastolic filling dynamics, characterized by rapid early diastolic filling followed by a plateau and reduced late diastolic filling. This is often accompanied by elevated filling pressures in both ventricles.

3. Pericardial Effusion: CCM may be associated with pericardial effusion, which can be visualized using echocardiography. Although pericardial effusion is not specific to CCM, its presence can aid in the diagnostic process and assessment of disease severity.

4. Respiratory Variation: Doppler echocardiography can demonstrate respiratory variation in mitral and tricuspid inflow velocities, known as the "ventricular interdependence" phenomenon. This occurs due to the exaggerated respiratory changes in intrathoracic pressure, leading to alterations in ventricular filling dynamics.

5. Thickened Pericardium: Echocardiography can also reveal thickening of the pericardium, which is a characteristic feature of chronic constrictive pericarditis. Although not specific to CCM, it can aid in distinguishing between different etiologies of restrictive cardiomyopathy.

6. Cardiac Chamber Dimensions: Echocardiography allows for the assessment of cardiac chamber dimensions, including the size of the atria and ventricles. In CCM, the atria may be enlarged due to chronically elevated filling pressures, whereas the ventricles may exhibit normal or reduced dimensions.

7. Differential Diagnosis: Echocardiography helps in differentiating CCM from other causes of restrictive cardiomyopathy, such as restrictive cardiomyopathy due to infiltrative diseases or myocardial fibrosis. Careful assessment of myocardial thickness, pericardial involvement, and ventricular function aids in making an accurate diagnosis.

In summary, echocardiography plays a pivotal role in the diagnosis and management of constrictive cardiomyopathy by providing valuable information about cardiac structure, function, and hemodynamics. Recognition of characteristic echocardiographic features is essential for accurate diagnosis and appropriate management of this challenging condition.

 

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...